Your browser doesn't support javascript.
loading
Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.
Shigekawa, Takashi; Osaki, Akihiko; Sekine, Hiroshi; Sato, Nobuaki; Kanbayashi, Chizuko; Sano, Hiroshi; Takeuchi, Hideki; Ueda, Shigeto; Nakamiya, Noriko; Sugitani, Ikuko; Sugiyama, Michiko; Shimada, Hiroko; Hirokawa, Eiko; Takahashi, Takao; Saeki, Toshiaki.
Affiliation
  • Shigekawa T; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. t.shigekawa@gmail.com.
  • Osaki A; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. aosaki@saitama-med.ac.jp.
  • Sekine H; Department of Radiation Oncology, Saitama Medical University International Medical Center, Saitama, Japan. h-sekine@jikei.ac.jp.
  • Sato N; Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan. nobus@niigata-cc.jp.
  • Kanbayashi C; Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan. kanba@niigata-cc.jp.
  • Sano H; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. h_sano@saitama-med.ac.jp.
  • Takeuchi H; Department of Surgery, Sasaki Memorial Hospital, Saitama, Japan. h_sano@saitama-med.ac.jp.
  • Ueda S; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. htake@saitama-med.ac.jp.
  • Nakamiya N; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. syueda2000@yahoo.co.jp.
  • Sugitani I; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. nakamiya@saitama-med.ac.jp.
  • Sugiyama M; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. nikoniko0215@hotmail.com.
  • Shimada H; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. michikos612@gmail.com.
  • Hirokawa E; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. h0113@saitama-med.ac.jp.
  • Takahashi T; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. eiko1126@saitama-med.ac.jp.
  • Saeki T; Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. ozokichilalakichi@yahoo.co.jp.
BMC Cancer ; 15: 253, 2015 Apr 10.
Article in En | MEDLINE | ID: mdl-25884795
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Breast Neoplasms / Tegafur / Chemotherapy, Adjuvant / Anthracyclines Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Breast Neoplasms / Tegafur / Chemotherapy, Adjuvant / Anthracyclines Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Country of publication: